ClinicalTrials.gg
Sign In

Chikungunya Fever clinical trials

The registry lists 88 studies for Chikungunya Fever across more than 10 countries. 21 are recruiting or about to start. 54 of them are mainly about Chikungunya Fever (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-16.

Get an email when these change. Save the Chikungunya Fever studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
47
Not yet recruiting
9
Recruiting
8
Active, not recruiting
6
Terminated
5
Status unknown
4

Phase

Phase 3
15
Phase 2
12
Phase 1
10
Early Phase 1
2
Phase 4
1

Where

United States
18
Brazil
14
France
10
Colombia
6
Mexico
5
Réunion
5

Who runs them

Valneva Austria GmbH (11) · National Institute of Allergy and Infectious Diseases (NIAID) (8) · Bavarian Nordic (7) · Centre Hospitalier Universitaire de la Réunion (6) · Themis Bioscience GmbH (4) · Institut Pasteur (3) · Bharat Biotech International Limited (2) · University of Notre Dame (2)

What is being tested here

Drugs under test in Chikungunya Fever studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Chikungunya vaccine147
Measles-Mumps-Rubella Vaccine001
Chloroquine011

Coming up

6phase 3 studies under way
5studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5, phase 3 first

Who these studies take

Of the 8 Chikungunya Fever studies recruiting now, 5 (63%) set no upper age limit and 3 (38%) stop at 75 or younger. 6 (75%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (25%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
103 (38%)3 (38%)
187 (88%)7 (88%)
307 (88%)7 (88%)
407 (88%)7 (88%)
507 (88%)7 (88%)
657 (88%)7 (88%)
756 (75%)6 (75%)
855 (63%)5 (63%)

Across all 88 studies, recruiting or not: 55% stop at 75 or younger and 48% at 65; 40% take children; 2% are for women only and 1% for men only; 59% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Chikungunya Fever studies take

Of 14 interventional studies with no phase under Chikungunya Fever, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase20 mo5–41 · 14 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 88. Browse all 88 → or search them.